# Westwood Holdings Group Inc: financial statements, quarterly

WHG · NYSE · CIK 1165002 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/whg.md) · [Financials](/companies/whg/financials.md) · [Filings](/companies/whg/filings.md) · [Insiders](/companies/whg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/whg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.9](/filings/0001165002-24-000076.md) | [19.4](/filings/0001165002-25-000022.md) | [22.7](/filings/0001165002-25-000037.md) | [22.7](/filings/0001165002-25-000048.md) | [23.7](/filings/0001165002-25-000059.md) | [20.5](/filings/0001165002-26-000020.md) | [23.3](/filings/0001165002-26-000034.md) | [23.1](/filings/0001165002-26-000049.md) | [24.3](/filings/0001165002-25-000059.md) | [27.1 d](/filings/0001165002-26-000020.md) | [25.0](/filings/0001165002-26-000034.md) | [25.3](/filings/0001165002-26-000049.md) |
| Operating income | $m | [(1.5)](/filings/0001165002-24-000076.md) | [2.8 d](/filings/0001165002-26-000020.md) | [2.9](/filings/0001165002-25-000037.md) | [(4.2)](/filings/0001165002-25-000048.md) | [(0.5)](/filings/0001165002-25-000059.md) | [2.6 d](/filings/0001165002-26-000020.md) | [(0.1)](/filings/0001165002-26-000034.md) | [0.9](/filings/0001165002-26-000049.md) | [2.0](/filings/0001165002-25-000059.md) | [2.2 d](/filings/0001165002-26-000020.md) | [(1.5)](/filings/0001165002-26-000034.md) | [2.1](/filings/0001165002-26-000049.md) |
| Income tax | $m | [(0.3)](/filings/0001165002-24-000076.md) | [1.2 d](/filings/0001165002-26-000020.md) | [1.4](/filings/0001165002-25-000037.md) | [(1.2)](/filings/0001165002-25-000048.md) | [0.3](/filings/0001165002-25-000059.md) | [1.3 d](/filings/0001165002-26-000020.md) | [0.1](/filings/0001165002-26-000034.md) | [0.4](/filings/0001165002-26-000049.md) | [1.0](/filings/0001165002-25-000059.md) | [1.1 d](/filings/0001165002-26-000020.md) | [0.0](/filings/0001165002-26-000034.md) | [0.7](/filings/0001165002-26-000049.md) |
| Net income | $m | [1.9](/filings/0001165002-25-000022.md) | [2.8](/filings/0001165002-25-000022.md) | [0.1](/filings/0001165002-26-000020.md) | [(0.4)](/filings/0001165002-26-000020.md) | [(1.2)](/filings/0001165002-26-000020.md) | [(3.1)](/filings/0001165002-26-000020.md) | [0.5](/filings/0001165002-26-000034.md) | [1.0](/filings/0001165002-26-000049.md) | [3.7](/filings/0001165002-25-000059.md) | [1.9 d](/filings/0001165002-26-000020.md) | [0.8](/filings/0001165002-26-000034.md) | [1.5](/filings/0001165002-26-000049.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001165002-25-000022.md) | [0.36](/filings/0001165002-25-000022.md) | [0.01](/filings/0001165002-26-000020.md) | [(0.05)](/filings/0001165002-26-000020.md) | [(0.15)](/filings/0001165002-26-000020.md) | [(0.40)](/filings/0001165002-26-000020.md) | [0.05](/filings/0001165002-26-000034.md) | [0.12](/filings/0001165002-26-000049.md) | [0.41](/filings/0001165002-25-000059.md) | not reported | [0.09](/filings/0001165002-26-000034.md) | [0.17](/filings/0001165002-26-000049.md) |
| Basic EPS | $ per share | [0.24](/filings/0001165002-25-000022.md) | [0.36](/filings/0001165002-25-000022.md) | [0.01](/filings/0001165002-26-000020.md) | [(0.05)](/filings/0001165002-26-000020.md) | [(0.15)](/filings/0001165002-26-000020.md) | [(0.40)](/filings/0001165002-26-000020.md) | [0.06](/filings/0001165002-26-000034.md) | [0.12](/filings/0001165002-26-000049.md) | [0.44](/filings/0001165002-25-000059.md) | not reported | [0.09](/filings/0001165002-26-000034.md) | [0.18](/filings/0001165002-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [17.2](/filings/0001165002-23-000084.md) | [20.4](/filings/0001165002-26-000020.md) | [25.9](/filings/0001165002-24-000039.md) | [23.8](/filings/0001165002-24-000065.md) | [22.8](/filings/0001165002-24-000076.md) | [18.8](/filings/0001165002-26-000020.md) | [9.4](/filings/0001165002-25-000037.md) | [15.4](/filings/0001165002-25-000048.md) | [21.6](/filings/0001165002-25-000059.md) | [26.2](/filings/0001165002-26-000049.md) | [23.4](/filings/0001165002-26-000034.md) | [22.6](/filings/0001165002-26-000049.md) |
| Current assets | $m | [66.2](/filings/0001165002-23-000084.md) | [72.2](/filings/0001165002-24-000076.md) | [66.5](/filings/0001165002-24-000039.md) | [63.9](/filings/0001165002-24-000065.md) | [68.6](/filings/0001165002-24-000076.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [151](/filings/0001165002-24-000076.md) | [155](/filings/0001165002-26-000020.md) | [149](/filings/0001165002-25-000037.md) | [147](/filings/0001165002-25-000048.md) | [152](/filings/0001165002-25-000059.md) | [150](/filings/0001165002-26-000020.md) | [135](/filings/0001165002-26-000034.md) | [146](/filings/0001165002-26-000049.md) | [154](/filings/0001165002-25-000059.md) | [162](/filings/0001165002-26-000049.md) | [150](/filings/0001165002-26-000034.md) | [155](/filings/0001165002-26-000049.md) |
| Current liabilities | $m | [16.5](/filings/0001165002-23-000084.md) | [18.6](/filings/0001165002-24-000076.md) | [14.6](/filings/0001165002-24-000039.md) | [13.4](/filings/0001165002-24-000065.md) | [16.2](/filings/0001165002-24-000076.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [30.9](/filings/0001165002-23-000084.md) | [32.7](/filings/0001165002-25-000022.md) | [25.3](/filings/0001165002-24-000039.md) | [26.9](/filings/0001165002-24-000065.md) | [31.1](/filings/0001165002-24-000076.md) | [27.7](/filings/0001165002-26-000020.md) | [13.6](/filings/0001165002-25-000037.md) | [23.9](/filings/0001165002-25-000048.md) | [28.1](/filings/0001165002-25-000059.md) | [35.6](/filings/0001165002-26-000049.md) | [24.3](/filings/0001165002-26-000034.md) | [27.9](/filings/0001165002-26-000049.md) |
| Shareholders' equity | $m | [120](/filings/0001165002-24-000076.md) | [122](/filings/0001165002-26-000034.md) | [121](/filings/0001165002-26-000049.md) | [120](/filings/0001165002-25-000048.md) | [120](/filings/0001165002-25-000059.md) | [122](/filings/0001165002-26-000049.md) | [121](/filings/0001165002-26-000034.md) | [122](/filings/0001165002-26-000049.md) | [124](/filings/0001165002-25-000059.md) | [126](/filings/0001165002-26-000049.md) | [125](/filings/0001165002-26-000034.md) | [126](/filings/0001165002-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,782) d](/filings/0001165002-24-000076.md) | [4,499 d](/filings/0001165002-26-000020.md) | [8,133](/filings/0001165002-25-000037.md) | [3,552 d](/filings/0001165002-25-000048.md) | [529 d](/filings/0001165002-25-000059.md) | [8,908 d](/filings/0001165002-26-000020.md) | [(4,900)](/filings/0001165002-26-000034.md) | [7,303 d](/filings/0001165002-26-000049.md) | [8,539 d](/filings/0001165002-25-000059.md) | [7,980 d](/filings/0001165002-26-000020.md) | [(2,567)](/filings/0001165002-26-000034.md) | [5,584 d](/filings/0001165002-26-000049.md) |
| Capital expenditure | $k | [22.0 d](/filings/0001165002-24-000076.md) | [28.0 d](/filings/0001165002-26-000020.md) | [3.0](/filings/0001165002-25-000037.md) | [21.0 d](/filings/0001165002-25-000048.md) | [10.0 d](/filings/0001165002-25-000059.md) | [75.0 d](/filings/0001165002-26-000020.md) | [6.0](/filings/0001165002-26-000034.md) | [0.0 d](/filings/0001165002-26-000049.md) | [76.0 d](/filings/0001165002-25-000059.md) | [4.0 d](/filings/0001165002-26-000020.md) | [246](/filings/0001165002-26-000034.md) | [534 d](/filings/0001165002-26-000049.md) |
| Dividends paid | $k | [1,221 d](/filings/0001165002-24-000076.md) | [1,228 d](/filings/0001165002-26-000020.md) | [1,724](/filings/0001165002-25-000037.md) | [1,259 d](/filings/0001165002-25-000048.md) | [1,226 d](/filings/0001165002-25-000059.md) | [1,231 d](/filings/0001165002-26-000020.md) | [1,575](/filings/0001165002-26-000034.md) | [1,281 d](/filings/0001165002-26-000049.md) | [1,262 d](/filings/0001165002-25-000059.md) | [1,247 d](/filings/0001165002-26-000020.md) | [1,625](/filings/0001165002-26-000034.md) | [1,322 d](/filings/0001165002-26-000049.md) |
| Share repurchases | $k | [0.0 d](/filings/0001165002-24-000076.md) | [0.0 d](/filings/0001165002-26-000020.md) | not reported | not reported | [273 d](/filings/0001165002-25-000059.md) | [0.0 d](/filings/0001165002-26-000020.md) | not reported | not reported | [0.0 d](/filings/0001165002-25-000059.md) | [0.0 d](/filings/0001165002-26-000020.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q3 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,794](/filings/0001165002-23-000084.md) | [7,969](/filings/0001165002-24-000039.md) | [8,131](/filings/0001165002-24-000065.md) | [8,117](/filings/0001165002-24-000076.md) | [8,392](/filings/0001165002-25-000037.md) | [8,219](/filings/0001165002-25-000048.md) | [8,488](/filings/0001165002-25-000059.md) | [8,782](/filings/0001165002-26-000034.md) | [8,814](/filings/0001165002-26-000049.md) | [8,941](/filings/0001165002-25-000059.md) | [9,042](/filings/0001165002-26-000034.md) | [9,080](/filings/0001165002-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,484,473 at 2026-02-27, from the cover of the [10-K filed 2026-03-04](/filings/0001165002-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.